Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CANGRELOR Cause Intentional product use issue? 11 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Intentional product use issue have been filed in association with CANGRELOR (Cangrelor). This represents 3.4% of all adverse event reports for CANGRELOR.

11
Reports of Intentional product use issue with CANGRELOR
3.4%
of all CANGRELOR reports
1
Deaths
1
Hospitalizations

How Dangerous Is Intentional product use issue From CANGRELOR?

Of the 11 reports, 1 (9.1%) resulted in death, 1 (9.1%) required hospitalization.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CANGRELOR. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does CANGRELOR Cause?

Off label use (144) Vascular stent thrombosis (29) Drug ineffective (26) Haemorrhage (22) Death (19) No adverse event (19) Inappropriate schedule of product administration (18) Cardiac arrest (15) Cardiogenic shock (14) Gastrointestinal haemorrhage (12)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which CANGRELOR Alternatives Have Lower Intentional product use issue Risk?

CANGRELOR vs CANIS LUPUS FAMILIARIS SKIN CANGRELOR vs CANNABIDIOL CANGRELOR vs CANNABIDIOL\HERBALS CANGRELOR vs CANNABIS SATIVA FLOWERING TOP CANGRELOR vs CANNABIS SATIVA SUBSP. INDICA TOP

Related Pages

CANGRELOR Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue CANGRELOR Demographics